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Research
AbstrACt
Objective To characterise incidence and healthcare 
costs associated with persistent postoperative pain (PPP) 
following lumbar surgery.
Design Retrospective, population-based cohort study.
setting Clinical Practice Research Datalink (CPRD) and 
Hospital Episode Statistics (HES) databases.
Participants Population-based cohort of 10 216 
adults who underwent lumbar surgery in England from 
1997/1998 through 2011/2012 and had at least 1 year of 
presurgery data and 2 years of postoperative follow-up 
data in the linked CPRD–HES.
Primary and secondary outcomes measures Incidence 
and total healthcare costs over 2, 5 and 10 years 
attributable to persistent PPP following initial lumbar 
surgery.
results The rate of individuals undergoing lumbar 
surgery in the CPRD–HES linked data doubled over 
the 15-year study period, fiscal years 1997/1998 to 
2011/2012, from 2.5 to 4.9 per 10 000 adults. Over the 
most recent 5-year period (2007/2008 to 2011/2012), 
on average 20.8% (95% CI 19.7% to 21.9%) of lumbar 
surgery patients met criteria for PPP. Rates of healthcare 
usage were significantly higher for patients with PPP 
across all types of care. Over 2 years following initial spine 
surgery, the mean cost difference between patients with 
and without PPP was £5383 (95% CI £4872 to £5916). 
Over 5 and 10 years following initial spine surgery, the 
mean cost difference between patients with and without 
PPP increased to £10 195 (95% CI £8726 to £11 669) 
and £14 318 (95% CI £8386 to £19 771), respectively. 
Extrapolated to the UK population, we estimate that nearly 
5000 adults experience PPP after spine surgery annually, 
with each new cohort costing the UK National Health 
Service in excess of £70 million over the first 10 years 
alone.
Conclusions Persistent pain affects more than one-in-
five lumbar surgery patients and accounts for substantial 
long-term healthcare costs. There is a need for formal, 
evidence-based guidelines for a coherent, coordinated 
management strategy for patients with continuing pain 
after lumbar surgery.
IntrODuCtIOn
Persistent postoperative pain (PPP) in lumbar 
surgery patients—more commonly known 
as failed back surgery syndrome—refers to 
chronic back and/or leg pain that continues 
or recurs in some patients following spinal 
surgery. It may be caused by one or a combi-
nation of factors including: residual or 
recurrent disc herniation, persistent postop-
erative compression of a spinal nerve, altered 
joint mobility, joint instability, postoperative 
strengths and limitations of this study
 ► This is the first study to estimate the occurrence of 
postoperative pain (PPP) following lumbar surgery 
using a sample of surgical patients selected from 
routinely collected UK hospital and primary care 
data.
 ► Our estimates of healthcare usage and costs are 
based on real-world experiences of the full range 
of lumbar surgery patients found in clinical practice.
 ► A limitation of using electronic medical records 
data is the classification of patients with PPP as 
there is no specific diagnosis code or set of codes 
for the condition of PPP and our data do not contain 
information on pain scores commonly used to 
assess the existence and severity of chronic pain 
following recovery from surgery.
 ► In contrast with previous studies that have relied on 
multiple assumptions regarding treatment patterns 
or on small and/or non-representative patient 
samples, we were able to calculate more precise 
estimates of PPP following lumbar surgery.
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myofascial pain development, scar tissue (fibrosis) and/
or spinal muscular deconditioning.1–3 Psychosocial factors 
that have been identified in this and other chronic post-
surgical pain conditions include preoperative anxiety, 
depression, poor coping strategies and pain catastroph-
ising. Litigation and worker’s compensation have also 
been associated with reports of ongoing pain.4 5 Patients 
form a diverse group, with complex and varied aetiologies 
and symptoms.6 7
Authoritative publications, mainly large case series and 
clinical trials, report that 10%–40% of all patients who 
undergo lumbar surgery develop some form of chronic 
PPP.8–16 The wide range of estimates reported reflect 
varying clinical experiences of different institutions and 
the small samples of patients on which these estimates are 
based. In 2013, Thompson took a mid-range estimate of 
20% failure applied to a rate of lumbar surgery in the 
UK population of 5 per 10 000 people and concluded that 
there are approximately 6000 new cases of PPP following 
spine surgery in the UK every year.17 More precise esti-
mates for the UK are not available.
Up-to-date, population-based estimates of incidence 
are required to keep pace with surgical advances and to 
inform healthcare system spending in this population. 
Using a formal and more rigorous epidemiological data-
driven approach, we aim to provide robust estimates of 
the incidence and healthcare costs associated with PPP 
following lumbar surgery in the UK over a 15-year period, 
from 1997/1998 to 2011/2012.
MethODs
Setting and data sources
This study employs a retrospective cohort design using 
two linked UK databases: the Hospital Episode Statis-
tics (HES) database and UK Clinical Practice Research 
Datalink (CPRD). An online supplementary appendix 
provides more detail on these data. Approval was granted 
by the Independent Scientific Advisory Committee for 
Medicines and Healthcare products Regulatory Agency 
on 17 December 2014 (ISAC Protocol 14-180R).
study participants
Incidence of lumbar surgery was calculated on a patient 
basis, as the number of patients aged 18 and above who 
underwent one or more lumbar procedures in a given 
fiscal year, expressed as a rate per 10 000 adults in the 
CPRD–HES linked dataset. Index-operative proce-
dures included any single procedure or combination 
of discectomy/microdiscectomy, excision of lumbar 
intervertebral disc, laminectomy, foraminotomy, lumbar 
decompression (or fenestration) or lumbar fusion 
(including all anterior and posterior approaches as well 
as combined approaches). Patients were required to 
have at least 2 years of follow-up data to allow sufficient 
time to observe criteria for PPP following the index 
surgery.
Definition of persistent PPP
From our lumbar surgery cohort, we categorised each 
individual as a ‘success’ (ie, no evidence of PPP) or 
‘failure’ (ie, evidence of PPP). Any one of the following 
three criteria, alone or in combination, was taken as 
evidence of pain continuing past the expected period for 
recovery following index lumbar surgery:
1. any additional lumbar surgery of any type occurring 
between 6 and 24 months postindex surgery;
2. a minimum of one pain-related physician visit in 
each of two consecutive quarters at any point during 
the 6–24 months postindex surgery identified using 
READ codes in CPRD or treatment specialty codes in 
the HES outpatient file;
3. any other surgical intervention (eg, neuromodulation, 
implantation of a drug infusion delivery system) to 
address pain occurring at any time, not limited to 24 
months after the index surgery, identified from either 
CPRD or the HES inpatient or outpatient datasets.
Prescription of analgesics (including opioids, non-ste-
roidal anti-inflammatory drugs, antidepressants or anti-
convulsants/antiepileptic drugs used for pain and other 
analgesic therapies for a period of at least 6 months from 
6 to 24 months postindex) was not by itself considered 
evidence of persistent PPP as patients may be prescribed 
analgesics for other painful conditions.
A minimum period of 3 months has been proposed 
for tissue healing after surgery, and this time period is 
also used to define chronicity of pain.18–20 We applied 
a more stringent, minimum 6-month period after the 
index lumbar surgery for patients to recover from 
normal, expected PPP. Any additional spine surgery that 
occurred during that period was assumed to be related 
to surgical complications of the index lumbar procedure, 
rather than the treatment of PPP. The literature suggests 
that some patients initially appear to improve following 
lumbar surgery but later become increasingly bothered 
by pain.4 6 21 Therefore, we allowed for a period of 18 
months (6–24 months postindex surgery) over which to 
evaluate evidence of unresolved, chronic pain based on 
recorded ongoing interventions.
healthcare usage and costs
A standard cost-of-illness approach22 23 was taken to esti-
mate total healthcare costs from the perspective of the 
UK National Health Service (NHS). We classified all 
healthcare encounters into major categories of health-
care resource usage and assigned unit costs following 
standard practice for cost-of-illness and cost-effective-
ness research (see online supplementary information on 
cost methodology and unit cost tables). Consistent with 
other studies of resource usage among similar popu-
lations,24 we estimated total cost per patient over 24 
months for all patients in our study (excluding the cost 
of the index surgery). We then extended our analysis out 
to 5 and 10 years postindex surgery among the subsets 
of patients with sufficient follow-up data. To account for 
inflation and variations in pricing over time, 2013 unit 
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costs were applied to all years. Total costs incorporated 
direct (including medical staff), indirect and overhead 
costs paid by the NHS. Finally, using these per patient esti-
mates, we projected the total number of PPP cases in the 
UK annually and the associated costs to the NHS.
statistical analyses
To estimate rates of PPP, we computed the number of 
patients who met our criteria for PPP as a percentage of 
all patients who underwent initial lumbar surgery within 
the time frame.
The comparison group of no persistent PPP was drawn 
from among lumbar surgery patients who fulfilled the 
‘no PPP’ criteria. We used 1:1 propensity score matching 
(without replacement) based on patient’s age at surgery, 
gender, year in which surgery took place, type of initial 
surgery (fusion vs decompression) and presence of 
each of 17 comorbidities that comprise the Charlson 
Comorbidity index (CCI) using the greedy matching 
algorithm.25–27
We estimated healthcare usage over a 2-year period 
for patients with PPP versus the matched controls and 
presented: (1) the proportion of patients who had a 
non-zero healthcare resource usage and the number of 
encounters by category (ie, primary care, inpatient care, 
outpatient attendances, outpatient procedures, accident 
and emergency care and prescriptions for pain medica-
tions) and (2) costs among users of the respective type 
of services/events (in order to provide insight into the 
intensity of resource usage among users of these services). 
Next, we estimated total healthcare costs by category of 
healthcare usage for all patients. Finally, we estimated the 
cost attributable to PPP as the difference in total costs 
for all PPP patients versus no PPP controls over the time 
periods 2, 5 and 10 years postindex surgery.
Statistical significance of differences between patients 
with and without PPP were evaluated using Fisher's exact 
tests for categorical predictor variables and Wilcoxon tests 
for continuous predictor variables. The main analyses 
compared the matched PPP cases and controls using Fish-
er’s exact tests for healthcare usage and bootstrapping for 
differences in average costs. All data manipulation and 
analyses were conducted using SAS software, V.9.4 for 
Windows (SAS Institute).
sensitivity analysis
In sensitivity analyses, we adjusted costs using generalised 
linear models (using log link and gamma distribution), 
extended estimating equations and ordinary least squares.
results
Rates of lumbar surgery in HES (among patients with linked 
CPRD data)
From the linked CPRD–HES database, we identified 
10 216 adults who underwent lumbar surgery from 
fiscal years 1997/1998 through 2011/2012 and who had 
at least 12 months of presurgery data (used to identify 
presurgical comorbid conditions and exclude those with 
previous lumbar surgery) and with 24 months follow-up. 
Our denominator for each year included all patients 
within the linked CPRD/HES dataset with at least 36 
months of follow-up to be comparable with the lumbar 
surgery group in that year. Incidence of PPP was adjusted 
to reflect the age and sex distribution of the UK popu-
lation in each year of the study.28 The age-adjusted/
sex-adjusted rate of lumbar surgeries grew steadily from 
2.41 per 10 000 in 1997/1998 to reach a peak of 4.94 per 
10 000 in 2010/2011 before falling slightly in 2011/2012 
to 4.70 per 10 000 (figure 1).
Percentage of lumbar surgery patients with persistent PPP 
(cases)
Of the 10 216 adults undergoing lumbar surgery in fiscal 
years 1997/1998–2011/2012, 1756 (17.2%; 95% CI 16.5% 
to 17.9%) patients met our criteria for PPP. Among 
patients with PPP, 85.4% were prescribed pain medication 
Figure 1 Age-adjusted and sex-adjusted incidence of lumbar surgery in linked Clinical Practice Research Datalink–Hospital 
Episode Statistics, rates per 10 000 adults.
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for at least 6 months compared with 50.3% of patients 
who did not meet PPP criteria.
Figure 2 shows the impact on our estimates of PPP from 
including the HES outpatient data, available from 2008 
onwards. The dotted line includes patients identified as 
having PPP using only the CPRD general practice file plus 
HES inpatient file. The solid line includes patients identi-
fied using these files plus the HES outpatient file, accred-
ited as a National Statistic since 2008. The percentage of 
patients with PPP captured without the HES outpatient 
file was fairly stable over the entire 15-year study period, 
but doubles with the inclusion of HES outpatient data. 
The percentage of patients with PPP early in the study 
period is likely to be underestimated as hospital pain 
clinic visits were not recorded. The more recent data are 
more likely to be reflective of current UK practice. On 
average, over the most recent 5-year period, 20.8% (95% 
CI 19.7% to 21.9%) of eligible patients met our criteria 
for PPP.
PPP cases versus lumbar surgery patients without PPP
Prior to matching, a comparison of patients with PPP 
versus those without showed that PPP patients were 
younger, more likely to be female and have a slightly 
higher comorbidity burden, as measured by the CCI. 
After propensity score matching, as expected, there were 
no significant differences between the cases and controls 
(table 1).
healthcare usage and cost
Compared with patients without, those with PPP had signifi-
cantly increased rates of healthcare usage for all healthcare 
encounter types. The difference was the largest for inpa-
tient hospital care at 77.5% for those with PPP versus 44.9% 
for those without. Patients with PPP were more than twice 
as likely as those without PPP to have had two or more inpa-
tient stays in the 2 years following index surgery.
Among those who used care in each of these settings, 
costs were in most cases significantly greater in the pres-
ence of PPP. In particular, PPP was associated with a three-
fold increase in average pain medication costs (£1165 
versus £382). Greater costs were also observed in inpa-
tient, outpatient hospital and primary care settings, indi-
cating greater intensity of resource usage for patients with 
PPP in each of these settings (table 2).
Comparing total costs for patients with PPP versus 
matched controls (no PPP) including both users and 
non-users of each service, we found that the mean addi-
tional cost attributable to PPP in the 2 years following 
surgery was £5383 per patient (table 3). Inpatient costs 
accounted for almost half (46.5%) of the cost differential 
and primary care contributed 26.9%.
Figure 2 Percentage of patients with postoperative pain (PPP) by year of index lumbar surgery. HES, Hospital Episode 
Statistics.
Table 1 Characteristics of lumbar surgery patients with and without postoperative pain (PPP) before and after selecting 
propensity score matched control group
Before matching After matching
No PPP PPP p Value No PPP PPP p Value
n=8460 n=1756 n=1756 n=1756
Age at surgery (years), mean (SD) 53.6
(16.0)
52.9
(15.5)
0.044 52.1
(16.0)
52.9
(15.5)
0.16
Male, % 50.7 43.3 <0.001 43.0 43.3 0.86
Charlson Comorbidity Index, mean (SD) 1.1
(2.0)
1.2
(2.0)
0.002 1.1
(1.8)
1.2
(2.0)
0.06
p Values were based on Fisher's exact tests for categorical and Wilcoxon tests for continuous variables.
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Table 2 Healthcare resource use and costs (2013 British pounds) in the 2-year period following index surgery among users of 
services, cases (postoperative pain (PPP)) versus propensity score matched controls (no PPP)
Healthcare usage Costs among users only
No PPP (n=1756) PPP (n=1756) No PPP PPP
n (%) n (%) mean (SD) mean (SD)
Any inpatient 788 (44.9) 1361 (77.5)** £3678 (4520) £5357 (5282)**
0 968 (55.1) 395 (22.5)
1 377 (21.5) 484 (27.6)
2 192 (10.9) 351 (20.0)
>2 219 (12.5) 526 (29.9)
Any outpatient 
attendances
1510 (86.0) 1606 (91.5)** £783 (975) £1316 (1149)**
0 246 (14.0) 150 (8.5)
1–6 904 (51.5) 438 (24.9)
7–12 349 (19.9) 512 (29.2)
>12 257 (14.6) 656 (37.4)
Any outpatient 
procedures
435 (24.8) 583 (33.2)** £540 (817) £664 (875)*
0 1321 (75.2) 1173 (66.8)
1 203 (11.6) 221 (12.6)
2 86 (4.9) 116 (6.6)
>2 146 (8.3) 246 (14.0)
Any accident and 
emergency
325 (18·5) 484 (27·6)** £257 (193) £265 (213) 
0 1431 (81.5) 1272 (72.4)
1 205 (11.7) 306 (17.4)
2 67 (3·8) 94 (5·4)
>2 53 (3.0) 84 (4.8)
Any primary care 1751 (99.7) 1756 (100.0)* £3178 (2560) £4616 (3011)**
Number of primary care 
visits, mean (SD)
73.3 (57.8) 107.5 (68.3)
Any pain drugs 1699 (96.7) 1750 (99.7)** £382 (2348) £1165 (4349)**
Number of 
prescriptions, mean (SD)
70.1 (98.6) 104.9 (104.0)
*p< 0.05 and **p<0.01 comparing rates of healthcare use (using Fisher’s exact tests) and mean costs (based on bootstrapping) among 
patients with PPP versus no PPP.
Table 3 Total 2-year costs (2013 British pounds), cases (postoperative pain (PPP)) versus propensity score matched control 
cohort (no PPP)
No PPP
(n=1756)
Mean (SD)
PPP
(n=1756)
Mean (SD) Difference (95% CIs)
Inpatient £1651 (3537) £4152 (5160) £2501 (2202 to 2811)
Outpatient attendances £673 (944) £1204 (1159) £531 (456 to 604)
Outpatient procedures £134 (469) £221 (593) £87 (51 to 121)
Accidents and emergency £48 (130) £73 (163) £25 (15 to 35)
Primary care £3169 (2562) £4616 (3011) £1447 (1263 to 1661)
Pain medications £370 (2310) £1161 (4342) £791 (574 to 1027)
Total costs £6044 (6712) £11 427 (9304) £5383 (4872 to 5916)
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When costs estimates were extended to 5 and 10 years 
following the index lumbar surgery, among patients with 
sufficient follow-up data for each period, the difference 
in costs between patients with and without PPP increased. 
In total, over 5 years following surgery, patients with PPP 
(n=894 cases) cost an additional mean of £10 195 (95% 
CI 8726 to 11 669), rising to a total mean cost differential 
of £14 318 (95% CI 8386 to 19 771) over 10 years (n=186 
cases). Note that the difference may have been underes-
timated for patients who underwent surgery prior to the 
release of the HES outpatient files in 2003/2004.
sensitivity analyses
Estimating the PPP cost differential with generalised 
linear models (using log link and gamma distribution), 
extended estimating equations and ordinary least squares 
produced very similar results to the main analysis.
DIsCussIOn
A total of 10 216 adults identified within the linked CPRD–
HES database underwent lumbar spinal surgery between 
1997/1998 and 2011/2012, with the rate of individuals 
receiving surgery approximately doubling over this time 
period. Using the criteria of additional lumbar surgery 
within 6–24 months, pain-related physician visits over at 
least two consecutive quarters within the same period 
or other surgical intervention therapy at any time, we 
estimate that approximately one in five (20.8%; 95% CI 
18.5% to 23.0%) lumbar spine surgery patients in the UK 
experience persistent PPP within 2 years of their index 
surgery. The costs of PPP patients over 10 years following 
lumbar surgery were more than 50% higher compared 
with those patients without ongoing pain.
Our estimate of PPP was conservative in that we did 
not include patients who had ongoing prescriptions for 
analgesic pain medications in the absence of other more 
rigorous indicators of back pain. If we had included any 
prescribing of pain medication, our estimate of post-
lumbar surgery PPP incidence would have risen from 
20.8% to 61.8%.
Our incidence estimate is consistent with a recent large 
Japanese study. Using internet-based survey data, the 
authors found that among 1842 respondents who self-re-
ported having undergone lumbar surgery in the past 10 
years, 20.6% experienced ongoing pain.29
strengths and limitations of this study
This study used routinely captured hospital and primary 
care data to investigate diagnoses and treatment patterns 
on a population sample of lumbar surgery patients. 
Hence, our observations are based on patterns of care 
for a large and representative group of patients under-
going treatment in real-world settings. This enabled us to 
calculate more precise estimates of PPP following lumbar 
surgery; previous studies have relied on multiple assump-
tions regarding treatment patterns or on randomised 
controlled clinical trial data with small, non-representa-
tive patient samples.
A limitation of using electronic medical records data 
is the classification of patients with PPP. There is no 
specific diagnosis code or set of codes for the condition 
of PPP. Instead, our estimates are based on presentation 
for further interventions, surgery and/or attendance at 
specialist pain clinics. The data do not contain informa-
tion on pain scores commonly used to assess the existence 
and severity of chronic pain following recovery from 
surgery. Evidence on the persistence of pain for a period 
of at least 6 months in the year following surgery was, by 
necessity, inferred from data on receipt of therapies for 
chronic pain, referrals to pain specialists, etc. It is possible 
that some patients who had a successful outcome of back 
surgery experienced ongoing concurrent or new onset 
chronic pain from another source and were misclassified 
as having postlumbar PPP.
Implications of our findings for policy and/or practice
Our findings are based on a broadly representative 
sample of the UK population undergoing lumbar surgery. 
The mid-2012 population estimate of adults in the UK 
was 50.2 million.30 Based on our estimates of lumbar 
surgery, we would predict that approximately 23 592 
patients underwent initial lumbar surgery in the UK at 
the end of our study period. This equates to 4907 adults 
(20.8%) with PPP following lumbar surgery annually in 
the UK and that the associated short-term (2 years) costs 
of caring for PPP amount to approximately £26.4 million 
for each new annual cohort of PPP patients. Extending 
our horizon to cover 10 years following index surgery, 
we would predict that each new annual cohort of lumbar 
surgery patients experiencing PPP could cost the NHS 
approximately £70.3 million over the first decade, with 
costs likely to continue accumulating over the remainder 
of the lifespan of members of that cohort.
Despite these large and ongoing costs, no formal 
guidelines to date have been put forward for the treat-
ment of persistent pain after lumbar surgery. Our find-
ings for patients with available follow-up data for 2, 5 and 
10 years postoperatively suggest that PPP patients have 
significantly higher resource usage and that these costs 
continue for at least a decade following index surgery. 
Although our data contained too few patients with more 
than 10 years of follow-up to extend our estimates beyond 
the initial decade, it is likely that the PPP cost differential 
persists into the long term particularly as patients’ age. 
Our 10-year estimate is a censored estimate of the total 
lifetime cost of managing these patients.
The growth in rates of lumbar surgery suggests that the 
numbers of patients living with ongoing pain in the UK 
is substantial and growing. In addition to the NHS cost 
burden, we know from other studies that these patients 
experience significant reduction in health-related quality 
of life. For example, in the PROCESS study, mean base-
line EQ5D index score among lumbar surgery patients 
with ongoing pain was 0.14,31 which is much lower than 
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has been documented for other patient populations with 
chronic diseases, including cancer.32 There is a need for a 
coherent management strategy for primary care staff, pain 
specialists and surgeons to offer to these patients. High-
quality primary studies are urgently required to provide 
more understanding of the treatment and recovery trajec-
tory of this patient group.
COnClusIOn
Using routinely collected clinical data, this study shows 
that approximately one-in-five lumbar spine surgery 
patients in the UK experience PPP (also known as ‘failed 
back surgery syndrome’). PPP is associated with higher 
rates of resource usage and with increased intensity of 
resource use in the inpatient, outpatient and primary 
care settings. The costs to the NHS of treating patients 
with PPP are substantive and remain elevated over time, 
highlighting the need for formalised national guidelines 
for the management of patients with lumbar pain presur-
gery and postsurgery.
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